Literature DB >> 25304615

Three novel fusion transcripts of the paired box 5 gene in B-cell precursor acute lymphoblastic leukemia.

Grazia Fazio1, Giulia Daniele2, Valeria Cazzaniga1, Luciana Impera3, Marco Severgnini4, Ilaria Iacobucci5, Marta Galbiati1, Anna Leszl6, Ingrid Cifola4, Gianluca De Bellis4, Paola Bresciani7, Giovanni Martinelli5, Giuseppe Basso6, Andrea Biondi8, Clelia Tiziana Storlazzi2, Giovanni Cazzaniga1.   

Abstract

Entities:  

Keywords:  B-cell precursor ALL; CHFR; PAX5; fusion gene

Mesh:

Substances:

Year:  2014        PMID: 25304615      PMCID: PMC4281328          DOI: 10.3324/haematol.2014.112193

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  14 in total

Review 1.  PAX5-AUTS2 fusion resulting from t(7;9)(q11.2;p13.2) can now be classified as recurrent in B cell acute lymphoblastic leukemia.

Authors:  E Coyaud; S Struski; N Dastugue; P Brousset; C Broccardo; J Bradtke
Journal:  Leuk Res       Date:  2010-08-17       Impact factor: 3.156

2.  Sequential array comparative genomic hybridization analysis identifies copy number changes during blastic transformation of chronic myeloid leukemia.

Authors:  Seung-Tae Lee; Yongick Ji; Hee-Jin Kim; Chang-Seok Ki; Chul Won Jung; Jong-Won Kim; Sun-Hee Kim
Journal:  Leuk Res       Date:  2012-02-05       Impact factor: 3.156

3.  Upregulation of the SOX5 by promoter swapping with the P2RY8 gene in primary splenic follicular lymphoma.

Authors:  C T Storlazzi; F Albano; C Lo Cunsolo; C Doglioni; M C Guastadisegni; L Impera; A Lonoce; S Funes; E Macrì; P Iuzzolino; I Panagopoulos; G Specchia; M Rocchi
Journal:  Leukemia       Date:  2007-06-07       Impact factor: 11.528

4.  A novel PAX5-ELN fusion protein identified in B-cell acute lymphoblastic leukemia acts as a dominant negative on wild-type PAX5.

Authors:  Marina Bousquet; Cyril Broccardo; Cathy Quelen; Fabienne Meggetto; Emilienne Kuhlein; Georges Delsol; Nicole Dastugue; Pierre Brousset
Journal:  Blood       Date:  2006-12-19       Impact factor: 22.113

5.  PAX5/ETV6 alters the gene expression profile of precursor B cells with opposite dominant effect on endogenous PAX5.

Authors:  G Fazio; V Cazzaniga; C Palmi; M Galbiati; M Giordan; G te Kronnie; A Rolink; A Biondi; G Cazzaniga
Journal:  Leukemia       Date:  2012-10-01       Impact factor: 11.528

6.  The paired box domain gene PAX5 is fused to ETV6/TEL in an acute lymphoblastic leukemia case.

Authors:  G Cazzaniga; M Daniotti; S Tosi; G Giudici; A Aloisi; E Pogliani; L Kearney; A Biondi
Journal:  Cancer Res       Date:  2001-06-15       Impact factor: 12.701

7.  Late-appearing pseudocentric fission event during chronic myeloid leukemia progression.

Authors:  Clelia Tiziana Storlazzi; Francesco Albano; Marija Dencić-Fekete; Vesna Djordjević; Mariano Rocchi
Journal:  Cancer Genet Cytogenet       Date:  2007-04-01

8.  Functional heterogeneity of PAX5 chimeras reveals insight for leukemia development.

Authors:  Klaus Fortschegger; Stefanie Anderl; Dagmar Denk; Sabine Strehl
Journal:  Mol Cancer Res       Date:  2014-01-16       Impact factor: 5.852

9.  Variable breakpoints target PAX5 in patients with dicentric chromosomes: a model for the basis of unbalanced translocations in cancer.

Authors:  Qian An; Sarah L Wright; Zoë J Konn; Elizabeth Matheson; Lynne Minto; Anthony V Moorman; Helen Parker; Mike Griffiths; Fiona M Ross; Teresa Davies; Andy G Hall; Christine J Harrison; Julie A Irving; Jon C Strefford
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-28       Impact factor: 11.205

10.  Molecular allelokaryotyping of pediatric acute lymphoblastic leukemias by high-resolution single nucleotide polymorphism oligonucleotide genomic microarray.

Authors:  Norihiko Kawamata; Seishi Ogawa; Martin Zimmermann; Motohiro Kato; Masashi Sanada; Kari Hemminki; Go Yamatomo; Yasuhito Nannya; Rolf Koehler; Thomas Flohr; Carl W Miller; Jochen Harbott; Wolf-Dieter Ludwig; Martin Stanulla; Martin Schrappe; Claus R Bartram; H Phillip Koeffler
Journal:  Blood       Date:  2007-09-21       Impact factor: 22.113

View more
  5 in total

1.  The role of the Janus-faced transcription factor PAX5-JAK2 in acute lymphoblastic leukemia.

Authors:  Dagmar Schinnerl; Klaus Fortschegger; Maximilian Kauer; João R M Marchante; Reinhard Kofler; Monique L Den Boer; Sabine Strehl
Journal:  Blood       Date:  2014-12-16       Impact factor: 22.113

2.  LCK over-expression drives STAT5 oncogenic signaling in PAX5 translocated BCP-ALL patients.

Authors:  Valeria Cazzaniga; Cristina Bugarin; Michela Bardini; Marco Giordan; Geertruy te Kronnie; Giuseppe Basso; Andrea Biondi; Grazia Fazio; Giovanni Cazzaniga
Journal:  Oncotarget       Date:  2015-01-30

3.  Conjoined Genes as Common Events in Childhood Acute Lymphoblastic Leukemia.

Authors:  Marco Severgnini; Mariella D'Angiò; Silvia Bungaro; Giovanni Cazzaniga; Ingrid Cifola; Grazia Fazio
Journal:  Cancers (Basel)       Date:  2022-07-20       Impact factor: 6.575

Review 4.  The Pleiotropy of PAX5 Gene Products and Function.

Authors:  Parinaz Nasri Nasrabadi; Danick Martin; Ehsan Gharib; Gilles A Robichaud
Journal:  Int J Mol Sci       Date:  2022-09-03       Impact factor: 6.208

5.  PAX5-KIAA1549L: a novel fusion gene in a case of pediatric B-cell precursor acute lymphoblastic leukemia.

Authors:  Stefanie Anderl; Margit König; Andishe Attarbaschi; Sabine Strehl
Journal:  Mol Cytogenet       Date:  2015-07-08       Impact factor: 2.009

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.